ERVW-1 and cancer: This delicate interaction between muscle and cancer cells is accompanied by several processes: an increase in IL-4 and IL-13 secretion, an overexpression of annexin A5 and syncytin 1 and a noticeable fusion of cancer cells (Uygur et al., 2019).